Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis

Autor: Oliver FitzGerald, Frank Behrens, Anne Barton, Heidi Bertheussen, Bruno Boutouyrie-Dumont, Laura Coates, Owen Davies, Maarten de Wit, Filippo Fagni, Carl S. Goodyear, Robert Gurke, Lisa Hahnefeld, Christine Huppertz, Vassilios Ioannidis, Mark Ibberson, Arnon Katz, Maximilian Klippstein, Michaela Koehm, Shimon Korish, Sina Mackay, David A. Martin, Denis O’Sullivan, Khadijah Patel, Stefan Rueping, Georg Schett, Klaus Scholich, Jochen M. Schwenk, Stefan Siebert, David Simon, Arani Vivekanantham, Stephen R. Pennington

Publikováno v: Therapeutic Advances in Musculoskeletal Disease, Vol 15 (2023)

Achieving a good outcome for a person with Psoriatic Arthritis (PsA) is made difficult by late diagnosis, heterogenous clinical disease expression and in many cases, failure to adequately suppress inflammatory disease features. Single-centre studies

Externí odkaz: https://doaj.org/article/a667e6ccef804442bb02abacbd1a08bf

Idiopathic pyostomatitis-pyodermatitis vegetans with nasal obstruction: A case report

Autor: Arnon Katz, Talia M Katz

Publikováno v: SAGE Open Medical Case Reports. 11:2050313X2311609

Pyostomatitis-pyodermatitis vegetans is an uncommon mucocutaneous dermatosis of unknown etiology. It presents as erythematous pustules that coalesce to form exudative vegetating plaques on the oral mucosa and/or skin. Diagnosis is largely based on cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::53aa89fa8258df3221cdc0499980074e
https://doi.org/10.1177/2050313x231160909

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Autor: Gordon, K. B, Blauvelt, A., Papp, K. A., Langley, R. G., Luger, T., Ohtsuki, M., Reich, K., Amato, D., Ball, S. G., Braun, D. K., Cameron, G. S., Erickson, J., Konrad, R. J., Muram, T. M., Nickoloff, B. J., Osuntokun, O. O., Secrest, R. J., Zhao, F., Mallbris, L., Leonardi, C. L., Uncover, 1 Study Group: Holly Hake Harris, Matheson, Robert T., Michael, Bukhalo, John H., Tu, Crowley, Jeffrey J., Grande, Kimberly K., Adnan, Nasir, Boni Elizabeth Elewski, James Alan Solomon, Liebhild, Stratmann, Claudia, Buettner, Thomas Peter Dirschka, Margrit Ruth Simon, Jens, Ulrich, Christine, Grigat, Mathias, Augustin, Andrei, Khariouzov, Gerhard, Sattler, Hans Michael Ockenfels, Fredrick Richard Behringer, Hector, Wiltz, Francisco, Flores, Kuettel, Kevin D., Ira Hughes Thorla, Jeffrey Keith Moore, Waterman, Gary L., George Joji Murakawa, Scott Alfred Fretzin, Frankel, Ellen H., Sunil Sharan Dhawan, Lucyna, Leszniewska, Maria, Poznanska, Anna Sobieszek Kundro, Chodorowska, Grazyna M., Katarzyna Turek Urasinska, Romuald, Maleszka, Andrzej, Kaszuba, Lidia, Rajzer, Elizbieta Barbara Szymanska, Lidia, Rudnicka, Neil James Korman, Jamie Debra Weisman, Truett, Artis P., Jeffry, Jacqmein, Steven Robert Cohen, Heller, Gary L., Jenkin, Peter J., Abe, Marcadis, George Sorin Tiplica, Anca Aghinitei Zbranca Toporas, Simona Laura Ianosi, Ion, Florea, Claus, Zachariae, Lars, Iversen, Annalisa, Patrizi, Romanelli, Marco, Christopher, Griffiths, John Berth Jones, John, Foerster, Savin, Ronald C., Nelson, Christopher G., Lyn Carol Chamberlain Guenther, Albrecht, Lorne E., Hong, Chih ho H., Arnon, Katz, Mani, Raman, Adam, David N., Aamir, Butt, Stephen Peter Shumack, Kurt Aaron Josef Gebauer, Lynda Jane Spelman, Shireen Kaur Sidhu, Michael George Freeman, Peter Anthony Foley, Lajos, Kemeny, Eva, Remenyik, Zsuzsanna, Karolyi, Marc, Bourcier, Wayne Douglas Carey, Victoria, Taraska, Derek, Haaland, Aditya Kumar Gupta, Catherine, Maari, Darryl Paul Toth, Michael, Sebastian, Sandra, Philipp, Roland, Kaufmann, Diamant, Thaci, Thomas Andreas Werfel, Leila, Parise, Ingo, Haase, Petra Staubach Renz, Shinichi, Imafuku, Juichiro, Nakayama, Tadashi, Terui, Hideki, Nakajima, Shigetoshi, Sano, Uncover, 2 Study Group, Uncover, 3 Study Group

Publikováno v: New England Journal of Medicine. 375:345-356

BACKGROUND Two phase 3 trials (UNCOVER-2 and UNCOVER-3) showed that at 12 weeks of treatment, ixekizumab, a monoclonal antibody against interleukin-17A, was superior to placebo and etanercept in the treatment of moderate-to-severe psoriasis. We repor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb30bf3a03c1849628a03f8c5fc3e43
https://doi.org/10.1056/nejmoa1512711

Strategic auditing of human and financial resource allocation in marketing

Autor: Pierre Filiatrault, Jean-Charles Chebat, Arnon Katz, Shlomo Mai Tal

Publikováno v: Journal of Business Research. 31:197-208

Data Envelopment Analysis (DEA) was used to assess the degree to which allocation of marketing resources affects the corporate profits of Canadian firms. The analysis was undertaken in five economic sectors. It shows that corporate profits are relate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae6ad68d4768fcd46c299aef06ba4774
https://doi.org/10.1016/0148-2963(94)90083-3

Pruritic Plaques on the Skin and Mucous Membranes

Autor: Lynn From, Arnon Katz, Cory C. Turner, R. Gary Sibbald

Publikováno v: Archives of Dermatology. 130:651

REPORT OF A CASE A 65-year-old man was referred for evaluation of a diffuse, pruritic eruption affecting his skin, conjunctiva, tongue, and oral cavity. The lesions first appeared on his face 2 years earlier and had slowly spread to involve most of h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97f051ed28202c464d9e9c15216988f9
https://doi.org/10.1001/archderm.1994.01690050119020